Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Highlights
San Antonio Breast Cancer Symposium (SABCS)
SABCS 2023 HR+/HER2- mBC
SABCS 2023 HR+/HER2- MBC
CDK4/6 Inhibitors in HER2-low Metastatic Breast Cancer
SABCS 2023 HR+/HER2- MBC
HER2 gene amplification may have impact on CDK 4/6 inhibitor-therapy effectiveness in patients with metastatic breast cancer.
Read More ›
Ribociclib Plus Endocrine Therapy Found to Improve Progression-Free Survival and Overall Survival in Elderly Patients
SABCS 2023 HR+/HER2- MBC
Pooled analysis of the MONALEESA-2, -3, and -7 clinical trials finds elderly patients have survival benefits from treatment with ribociclib plus endocrine therapy.
Read More ›
Clinical Meaningfulness Poorly Understood and Often Not Considered in the Metastatic Breast Cancer Clinical Setting
SABCS 2023 HR+/HER2- MBC
Focus group analysis of stakeholders in metastatic breast cancer treatment finds a need for accessible and patient-friendly terminology in metastatic breast cancer treatment-making discussions.
Read More ›
CDK4/6 Inhibitors Plus Radiotherapy for Patients With HR+/HER2– Advanced Breast Cancer With Brain Metastases
SABCS 2023 HR+/HER2- MBC
The use of CDK4/6 inhibitors following radiotherapy demonstrated to be safe and effective in patients with HR+/HER2– advanced breast cancer who develop brain metastases.
Read More ›
First-Line Treatment Sequencing Associated With an Improved Progression-Free Survival in Patients With Metastatic Breast Cancer
SABCS 2023 HR+/HER2- MBC
Recent retrospective study finds that receiving CDK4/6 inhibitor plus endocrine therapy improves progression-free survival in patients with HR+/HER2– metastatic breast cancer.
Read More ›
Page 2 of 2
1
2
Conference Correspondent Coverage is Brought to You by the Publishers of:
Learn more about our family of publications.
View Our Publications
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us